7 October, 2026 Melbourne, Australia CSL prices US$1.5 billion in Corporate Bonds CSL Limited (ASX:CSL; USOTC:CSLLY) today announces it has priced US$1.5 billion of corporate bonds in the US Dollar 144A / Reg S market. The notes will be issued by CSLB Holdings Inc. and guaranteed by the parent...
CSL prices US$1.5 billion in Corporate Bonds
Filed with ASX ·
Watch CSL's latest callCSL (ASX:CSL) Q4 2026 Earnings Call · Replay · Aug 18Read the transcript of CSL (ASX:CSL) Q4 2026 Earnings Call6ix hasn’t read this filing yet.
Earlier from CSL
- CSL and Alentis announce global partnership to develop and commercialise lixudebart for rare kidney and liver diseases
- CSL และ Alentis ประกาศความร่วมมือระดับโลก เพื่อพัฒนาและทำการตลาดยา lixudebart สำหรับโรคไตและตับที่พบได้ยาก
- CSL enters exclusive agreement with Alentis Therapeutics
- CSL Seqirus Expands U.S. Availability of Influenza Vaccine following Successful Completion of the 2026/27 Manufacturing Campaign
- Update - Notification of buy-back - CSL
Later from CSL
- CSL dan Alentis umum perkongsian global untuk membangunkan dan mengkomersialkan lixudebart bagi penyakit buah pinggang dan hati yang jarang berlaku
- Update on U.S. Plasma Collection Network
- Appointment of New CEO
- CSL appoints Deborah Waterhouse as CEO & Managing Director
- CSL to Defend Class Action
Follow CSL into a list and get an email when it puts out news.
Follow CSL